China Jo-Jo Drugstores, Inc. (CJJD)
USD 1.52
(-5.59%)
USD 1.52
(-5.59%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 10.34 Million USD | -1.19% |
| 2023 | 23.34 Million USD | -22.73% |
| 2022 | 30.21 Million USD | 22.15% |
| 2021 | 24.73 Million USD | -35.37% |
| 2020 | 38.27 Million USD | 130.16% |
| 2019 | 16.62 Million USD | 310.85% |
| 2018 | 4.04 Million USD | 171.35% |
| 2017 | -5.67 Million USD | -151.78% |
| 2016 | 10.95 Million USD | -6.86% |
| 2015 | 11.76 Million USD | 206.96% |
| 2014 | 3.83 Million USD | 43.92% |
| 2013 | 2.66 Million USD | 608.62% |
| 2012 | 375.71 Thousand USD | 109.93% |
| 2011 | -3.78 Million USD | -345.34% |
| 2010 | 1.54 Million USD | 96167.75% |
| 2009 | -1606.00 USD | 94.71% |
| 2008 | -30.35 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | 10.34 Million USD | 24.97% |
| 2024 Q1 | 13.31 Million USD | -42.96% |
| 2024 Q3 | 18.46 Million USD | 149.1% |
| 2024 FY | 10.34 Million USD | -55.69% |
| 2024 Q2 | 7.41 Million USD | -44.36% |
| 2023 Q3 | 18.21 Million USD | -33.81% |
| 2023 FY | 23.34 Million USD | -22.73% |
| 2023 Q1 | 22.45 Million USD | -25.67% |
| 2023 Q2 | 27.52 Million USD | 22.54% |
| 2023 Q4 | 23.34 Million USD | 28.17% |
| 2022 Q1 | 25.98 Million USD | 5.05% |
| 2022 FY | 30.21 Million USD | 22.15% |
| 2022 Q4 | 30.21 Million USD | 12.38% |
| 2022 Q3 | 26.88 Million USD | -2.4% |
| 2022 Q2 | 27.54 Million USD | 6.01% |
| 2021 Q1 | 33.59 Million USD | -12.23% |
| 2021 Q3 | 40.62 Million USD | 50.99% |
| 2021 FY | 24.73 Million USD | -35.37% |
| 2021 Q2 | 26.9 Million USD | -19.9% |
| 2021 Q4 | 24.73 Million USD | -39.12% |
| 2020 Q2 | 18.7 Million USD | -35.26% |
| 2020 FY | 38.27 Million USD | 130.16% |
| 2020 Q3 | 30.05 Million USD | 60.7% |
| 2020 Q4 | 38.27 Million USD | 27.34% |
| 2020 Q1 | 28.89 Million USD | 73.74% |
| 2019 Q3 | 19.65 Million USD | 128.86% |
| 2019 Q1 | 4.65 Million USD | 14.99% |
| 2019 FY | 16.62 Million USD | 310.85% |
| 2019 Q4 | 16.62 Million USD | -15.38% |
| 2019 Q2 | 8.58 Million USD | 84.49% |
| 2018 Q2 | -3.96 Million USD | -236.72% |
| 2018 FY | 4.04 Million USD | 171.35% |
| 2018 Q4 | 4.04 Million USD | -63.16% |
| 2018 Q3 | 10.98 Million USD | 377.06% |
| 2018 Q1 | -1.17 Million USD | 79.24% |
| 2017 Q2 | 3.35 Million USD | -48.79% |
| 2017 Q1 | 6.54 Million USD | -40.25% |
| 2017 FY | -5.67 Million USD | -151.78% |
| 2017 Q4 | -5.67 Million USD | -174.63% |
| 2017 Q3 | 7.6 Million USD | 126.76% |
| 2016 Q1 | 17.87 Million USD | 51.98% |
| 2016 FY | 10.95 Million USD | -6.86% |
| 2016 Q4 | 10.95 Million USD | -13.94% |
| 2016 Q3 | 12.72 Million USD | 24.35% |
| 2016 Q2 | 10.23 Million USD | -42.73% |
| 2015 Q3 | 13.45 Million USD | 226.55% |
| 2015 Q4 | 11.76 Million USD | -12.57% |
| 2015 FY | 11.76 Million USD | 206.96% |
| 2015 Q1 | 5.92 Million USD | 54.52% |
| 2015 Q2 | 4.11 Million USD | -30.42% |
| 2014 Q3 | 5.1 Million USD | 1132.47% |
| 2014 FY | 3.83 Million USD | 43.92% |
| 2014 Q1 | 4.58 Million USD | 72.3% |
| 2014 Q4 | 3.83 Million USD | -24.9% |
| 2014 Q2 | 413.99 Thousand USD | -90.98% |
| 2013 Q4 | 2.66 Million USD | -9.55% |
| 2013 FY | 2.66 Million USD | 608.62% |
| 2013 Q1 | 1.99 Million USD | 429.87% |
| 2013 Q2 | 3.03 Million USD | 52.39% |
| 2013 Q3 | 2.94 Million USD | -2.98% |
| 2012 Q3 | 497.03 Thousand USD | 123.72% |
| 2012 Q1 | -4.17 Million USD | -10.29% |
| 2012 Q4 | 375.71 Thousand USD | -24.41% |
| 2012 FY | 375.71 Thousand USD | 109.93% |
| 2012 Q2 | -2.09 Million USD | 49.8% |
| 2011 FY | -3.78 Million USD | -345.34% |
| 2011 Q1 | -12.71 Million USD | -924.1% |
| 2011 Q4 | -3.78 Million USD | 9.11% |
| 2011 Q3 | -4.16 Million USD | 64.17% |
| 2011 Q2 | -11.62 Million USD | 8.6% |
| 2010 Q2 | 955.2 Thousand USD | 138335.31% |
| 2010 Q1 | -691.00 USD | -109.07% |
| 2010 FY | 1.54 Million USD | 96167.75% |
| 2010 Q4 | 1.54 Million USD | 60.56% |
| 2010 Q3 | 960.88 Thousand USD | 0.59% |
| 2009 Q4 | 7619.00 USD | 51.59% |
| 2009 Q2 | -463.00 USD | 71.17% |
| 2009 FY | -1606.00 USD | 94.71% |
| 2009 Q3 | 5026.00 USD | 1185.53% |
| 2009 Q1 | -1606.00 USD | 71.36% |
| 2008 Q2 | -29.49 Thousand USD | 0.0% |
| 2008 FY | -30.35 Thousand USD | 0.0% |
| 2008 Q4 | -5607.00 USD | 74.99% |
| 2008 Q3 | -22.41 Thousand USD | 24.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | -655.73 Thousand USD | 1677.751% |
| BIMI International Medical Inc. | 3.11 Million USD | -231.733% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 116.41 Million USD | 91.113% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 109.08 Million USD | 90.516% |
| Leafly Holdings, Inc. | 13.79 Million USD | 24.987% |
| Leafly Holdings, Inc. | 13.79 Million USD | 24.987% |
| LifeMD, Inc. | -14.21 Million USD | 172.784% |
| LifeMD, Inc. | -14.21 Million USD | 172.784% |
| TRxADE HEALTH, Inc. | 6.95 Million USD | -48.817% |
| PetMed Express, Inc. | -53.84 Million USD | 119.215% |
| Walgreens Boots Alliance, Inc. | 8.23 Billion USD | 99.874% |